使用拓描述符预测抗失律药物的物理化学特性的一种python方法
Huiling Qin1, Mudassar Rehman2, Muhammad Farhan Hanif3
1Department of Rehabilitation Medicine, The Affiliated Hospital of Youjiang Medical University for Nationalities, Baise, China.
Scientific reports
|January 11, 2025
概括
这项研究开发了一种机器学习定量结构-属性关系 (QSPR) 模型,用于预测抗心律失常药物的物理化学特性. 该模型准确地预测了诸如极化性之类的特性,有助于药物开发.
科学领域:
- 计算化学计算化学
- 药用化学 医学化学
- 药理学 药理学是指药理学的学科.
背景情况:
- 机器学习 (ML) 越来越多地用于预测药品的化学和生物特性.
- 开发抗心律失常药物是复杂的,因为化学结构和疗效之间的复杂联系.
- 预测建模可以简化抗心律失常药物候选者的识别和优化.
研究的目的:
- 开发基于机器学习的定量结构与属性关系 (QSPR) 模型.
- 通过拓描述器预测抗心律失常药物的关键物理化学特性.
- 提高对抗心律失常药物设计中的结构性质关系的理解.
主要方法:
- 应用机器学习技术,包括线性回归模型.
- 使用K折交叉验证来进行可靠的模型评估.
- 采用拓描述符来表示十种抗失常药物的化学结构.
主要成果:
- 成功预测了物理化学特性,如密度,沸点,闪点,生物度因子 (BCF),有机碳分割系数 (KOC),极化性和摩尔体积.
- 实现了显著的预测性能,使用R和[公式:参见文本]等指标进行评估.
- 确定,当使用包含H(G) 和[公式:参见文本]描述符的模型时,极化性预测最准确.
结论:
- 开发的QSPR模型证明了机器学习在预测抗心律失常药物特性方面的实用性.
- 拓描述符与ML相结合,为理解结构与属性关系提供了一种有价值的方法.
- 这种预测能力可以加速开发新型和有效的抗失常疗法.
相关概念视频
01:22Antiarrhythmic Drugs: Class I Agents as Sodium Channel Blockers
1.2K
Class I antiarrhythmic drugs are used to treat various types of arrhythmias or irregular heart rhythms. These drugs block the sodium (Na+) channels in the cardiac cells, thereby affecting the movement of electrical impulses across the heart. Class I antiarrhythmic drugs are divided into three subgroups: Class IA, Class IB, and Class IC, each with distinct mechanisms of action and effects on the heart.
Class 1A Antiarrhythmic Drugs: These drugs work by moderately blocking sodium channels,...
Class 1A Antiarrhythmic Drugs: These drugs work by moderately blocking sodium channels,...
1.2K
01:12Antiarrhythmic Drugs: Class III Agents as Potassium Channel Blockers
899
Class III antiarrhythmic drugs are a group of medications that can prolong action potentials in the heart. They achieve this by blocking potassium channels or enhancing inward currents from sodium channels. However, these drugs have a unique property of "reverse use-dependence," which is most pronounced at slower heart rates and can lead to torsades de pointes—a specific type of arrhythmia. However, it is essential to note that excessive QT interval prolongation—a measure of...
899
01:24Antiarrhythmic Drugs: Class II Agents as β-Adrenergic Blockers
707
Adrenergic stimulation generally impacts cardiac rate and rhythm. Specifically, stimulation of the β-adrenoceptors triggers an increase in intracellular calcium ion influx and pacemaker currents, which may cause arrhythmias. Catecholamines like adrenaline also demonstrate β2-adrenoceptor-mediated hypokalemia, impacting cardiac action potential and disrupting the normal cardiac rhythm. Class II antiarrhythmic drugs are β-adrenoceptor antagonists or β-blockers, which...
707
01:20Antiarrhythmic Drugs: Class IV Agents as Calcium Channel Blockers
769
Class IV antiarrhythmic drugs, such as verapamil and diltiazem, block calcium channels. They primarily affect the heart, slowing the conduction in calcium-dependent tissues like the SA and AV nodes. These drugs manage reentrant supraventricular tachycardia (SVT) and reduce ventricular rate in atrial flutter/fibrillation.
Verapamil, a calcium channel blocker, inhibits calcium movement across myocardial cell membranes and vascular smooth muscle. This results in the dilation of coronary and...
Verapamil, a calcium channel blocker, inhibits calcium movement across myocardial cell membranes and vascular smooth muscle. This results in the dilation of coronary and...
769
01:28Structure-Activity Relationships and Drug Design
493
Drug design is a dynamic field that involves discovering and developing new medications based on specific biological targets. This process heavily relies on structure-activity relationships (SAR) and quantitative structure-activity relationships (QSAR) to guide the design and optimization of efficient drugs.
SAR studies the intricate relationship between a drug's chemical structure and biological activity. It focuses on understanding how modifications to a drug's structure can influence...
SAR studies the intricate relationship between a drug's chemical structure and biological activity. It focuses on understanding how modifications to a drug's structure can influence...
493
01:18Cardiovascular Drugs: Classification based on Therapeutic Indications
2.0K
Cardiovascular diseases, encompassing a range of conditions, can significantly affect the heart's operations and the overall circulatory system. These conditions impair the heart's ability to pump blood, leading to a deficit in oxygen supply to crucial organs. Anomalies in the heart's electrical system, known as arrhythmias, can cause heartbeats to accelerate or slow down. Usually, heart rates increase during physical activity and decrease while resting or sleeping. However,...
2.0K